Allied Market Research

Metabolomics Market Expected to Reach $3,301 Million by 2023


Report Code : A00423

quote Metabolomics is an innovative approach for the treatment and diagnosis of chronic diseases. Increased adoption of metabolomics in drug development and personalized healthcare is expected to fuel the market growth during the forecast period. quote

Sriram Radhakrishnan
Team Lead, Healthcare at AMR

Get 20% Free Customization In This Report
Follow us on Social Media:       

According to a new report published by Allied Market Research, titled, Metabolomics Market by Product & Service, Application, and Indication: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global metabolomics market accounted for $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023. North America was the highest contributor to the global metabolomics market in 2016; while, Asia-Pacific is anticipated to witness the highest growth rate throughout the forecast period.

Access Full Summary at:

Metabolomics uses various analytical methods, such as spectroscopy, chromatography, and multivariate analysis, for the identification & quantification of various metabolites. The analytical methods facilitate the classification of various known & unknown metabolites in the reaction. The comprehensive nature of metabolites enables its application in diverse medical fields; thereby, facilitating the development of new therapeutic procedures and diagnostics tests.

The global metabolomics market is expected to grow at a lucrative rate during the forecast period due to increased adoption of metabolomics in precision medicine and surge in R&D investments. Moreover, technological advancements in auxiliary medical devices used for metabolomics analysis and growth in demand for the development of quality medications are expected to fuel the metabolomics market. However, high cost of medical devices and lack of effective data management for metabolomic profiling hamper the market growth.

The biomarker discovery segment accounted for the highest market share in 2016, and is expected to continue this trend during the forecast period. Technological advancements in quantification methods & technologies and increase in concerns related to prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer, are expected to drive the growth of this segment.

Key Findings of the Metabolomics Market:

  • The drug discovery segment is estimated to grow at the highest rate during the forecast period.
  • The biomarker discovery segment generated the highest revenue in 2016, and is expected to continue its dominance in the near future.
  • North America dominated the global market in 2016.
  • China is expected to grow at the highest CAGR in the Asia-Pacific region.

North America accounted for the highest market share in 2016, owing to surge in R&D investment and availability of modern healthcare facilities. Moreover, increased use of experimental medicines and growth in adoption of metabolomics in precision medicine are expected to boost the North America metabolomics market. However, Asia-pacific is expected to grow at the highest CAGR during the forecast period due to rapid adoption of metabolomics in medical research, increase in disposable income, and surge in government initiatives to discover cost-effective treatments for chronic diseases.

The key companies profiled in the report include Agilent Technologies, Inc., Danaher Corporation, Biocrates Life Sciences AG, Bruker Corporation, Leco Corporation, Metabolon, Inc., Human Metabolome Technologies, Inc., Bio-Rad Laboratories, Inc., Shimadzu Corporation, Waters Corporation, and Thermo Fisher Scientific Inc.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975



For Media Inquiries, Please Contact

Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote Metabolomics Market by Product & Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools and Services), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023 quote

View Report
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.


Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Metabolomics Market"
Purchase Enquiry